A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis

NCT03161457 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

153

Enrollment

INDUSTRY

Sponsor class

Stopped The development was stopped due to company's strategy consideration

Conditions

Rheumatoid Arthritis
Arthritis, Rheumatoid

Interventions

BIOLOGICAL: JHL1101
BIOLOGICAL: MabThera

Sponsor

JHL Biotech, Inc.